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During the transition from the inner cell mass (ICM)
cells of blastocysts to pluripotent embryonic stem
cells (ESCs) in vitro, a normal developmental pro-
gram is replaced in cells that acquire a capacity for
infinite self-renewal and pluripotency. We explored
the underlying mechanism of this switch by using
RNA-Seq transcriptome analysis at the resolution
of single cells. We detected significant molecular
transitions and major changes in transcript variants,
which include genes for general metabolism. Fur-
thermore, the expression of repressive epigenetic
regulators increased with a concomitant decrease
in gene activators that might be necessary to
sustain the inherent plasticity of ESCs. Furthermore,
we detected changes in microRNAs (miRNAs), with
one set that targets early differentiation genes while
another set targets pluripotency genes to maintain
the unique ESC epigenotype. Such genetic and
epigenetic events may contribute to a switch from
a normal developmental program in adult cells
during the formation of diseased tissues, including
cancers.
INTRODUCTION
The derivation of embryonic stem cells (ESCs) from the inner cell
mass (ICM) of mouse blastocysts consisting of about 20 cells
occurs in vitro under a variety of culture conditions, such as in
the presence of leukemia inhibitory factor (LIF) and fetal calf
serum (FCS) (Evans and Kaufman, 1981; Ying et al., 2008). After
about 5 days in culture, the inner cell mass outgrowths of blasto-
cysts are disrupted into small clusters of cells and passaged until
the establishment of ESC lines. Thus, the ICM cells that, in vivo,
are subject to a strict developmental program undergo a trans-
formation into cells with a capacity for infinite self-renewal while
retaining pluripotency. The precise molecular changes accom-
panying this transition remain to be fully elucidated, which is468 Cell Stem Cell 6, 468–478, May 7, 2010 ª2010 Elsevier Inc.hampered by the limited number of cells available for analysis
(Niwa, 2007).
Pluripotent E3.5-E4.5 primitive ectoderm/epiblast (PE) and
ESCs can both contribute to all three germ layers and the
germ line when injected into host blastocysts to form chimera
(Niwa, 2007). However, only the ESCs cultured in vitro have the
capacity for unlimited self-renewal while retaining their pluripo-
tency (Niwa, 2007; Smith, 2006). Some differences between
the ICM and ESCs have been identified, such as the expression
of pramel5, pramel6, and pramel7 in the ICM, which are
repressed in ESC (Kaji et al., 2007). Other genes, including Dicer
(Bernstein et al., 2003; Kanellopoulou et al., 2005; Murchison
et al., 2005), Nanog (Chambers et al., 2007; Chambers et al.,
2003; Mitsui et al., 2003), Mbd3 (Kaji et al., 2006; Kaji et al.,
2007), and Ezh2 (O’Carroll et al., 2001; Shen et al., 2008), are
essential for the establishment of pluripotent PE cells in the
ICM but dispensable for the maintenance of ESCs.
There have been intensive studies on ESCs in recent years, but
these have usually been on bulk cells by RNA-Seq, cDNAmicro-
array, SAGE, and EST sequencing (Niwa, 2007; Ivanova et al.,
2006; Cloonan et al., 2008). However, the precise changes
accompanying the process of conversion of ICM to ESCs remain
to be fully elucidated. To gain insight into this process, we used
blastocysts from Oct4-DPE-GFP transgenic mice and cultured
them in vitro under the classical conditions consisting of LIF
and FCS used for the derivation of ESCs (Niwa, 2007). The
Oct4-DPE-GFP reporter we used is under the control of only
the distal enhancer for Oct4 (also known as Pou5f1) and lacks
the proximal enhancer (Yeom et al., 1996). This GFP reporter
shows expression in the E3.5 ICM, E4.5 epiblast, primordial
germ cells (PGCs), and ESCs, but not in the postimplantation
epiblast or in the epiblast stem cells (EpiSCs) (Yeom et al.,
1996; Bao et al., 2009). Notably, the distal enhancer of Oct4
represents the densest binding locus for the key pluripotency-
specific transcription factors in ESCs (Chen et al., 2008), which
makes it an ideal reporter for tracing the course of changes
during the establishment of ESCs from ICM. By analyzing single
Oct4-DPE-GFP-positive and Oct4-DPE-GFP-negative cells, we
set out to monitor changes in ICM cells during their progression
toward ESCs. We used our recently developed single-cell
RNA-Seq transcriptome analysis to investigate the critical early
changes during this process (Tang et al., 2009).
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Analysis of Individual ICM Outgrowth Cells
First, we analyzed the three key pluripotency genes during the
course of blastocyst culture and the formation of outgrowths
(Figure 1). At each stage, we chose between 10 and 26 single
cells for analysis. We generated cDNAs by whole transcriptome
amplification (WTA) of these individual cells (see Experimental
Procedures for details). All ICM cells (22/22) tested showed
high expression of Oct4, Sox2, and Nanog. However, among
cells from day 3 outgrowths that had high Oct4 expression,
about 39% (7/18) had already lost expression of Nanog and/or
Sox2, indicating that they might be losing pluripotency. By
contrast, most of the cells from day 5 outgrowths (11/13) that
had high Oct4 expression also showed high expression of both
Sox2 and Nanog, suggesting that these may represent the
earliest population that had acquired or were likely on course
to acquire the ESC-like fate with the potential for self-renewal.
We were also able to establish an ESC line from a single cell iso-
lated from a day 5 outgrowth (data not shown). As expected, all
the ESCs (23/23) had high expression of these three pluripotency
genes.
Expression Dynamics of 385 Genes in 74 Single Cells
from ICM to ESCs
Next, we chose 385 pluripotency and early differentiation related
genes tomonitor their expression in cells from the ICM, aswell as
from day 3 and day 5 outgrowths, and from ESCs at single-cell
resolution (Table S1). All 14 ESCs analyzed had high expression
(Ct = 19–28) of Oct4, Sox2, Nanog, Dppa4, Dppa5, Sall4, Utf1,
Rex2, and Rif1, indicating their pluripotent character (Figure 2A
and Figure S1). By contrast, we detected little or no expression
(Ct = 40) of all 23 early differentiation marker genes (ectoderm
markers: Pax6, Otx1, Neurod1, Nes, Lhx5, and Hoxb1; meso-
dermmarkers: Tbx2, T,Nkx2-5,Myod1,Myf5,Mesdc1,Mesdc2,
Kdr, Isl1, Hand1, and Eomes; endoderm markers: Onecut1,
Gata4, Gata5, and Gata6; extraembryonic markers: Cdx2 and
Tpbpa) (see Table S1). Similarly, all 14 cells isolated and
analyzed from ICM showed high expression of the nine pluripo-
tency-specific genes. However, expression of some genes, for
example, c-Myc, which was shown to be an important reprog-
ramming factor for pluripotency (Takahashi and Yamanaka,
2006), was highly heterogeneous in cells from the ICM
(Ct = 24–40); this variability was progressively reduced until,
finally, all ESCs consistently expressed c-Myc (Figure 2B). Inter-
estingly, we found that Tet1 and Tet2 (Table S1), which were
recently shown to mediate DNA demethylation in ESCs, were
highly expressed in both ICM and ESCs, but their expression
only decreased in Oct4-negative cells present in the ICM
outgrowths. Thus, our observations support their importance
for pluripotency (Tahiliani et al., 2009).
Since ESCs can also bemaintained in an undifferentiated state
by LIF and BMP4 (Ying et al., 2003), we investigated the expres-
sion of a key receptor,Bmpr1a, and found it to be heterogeneous
in the ICM (Ct = 27–40). However during the ICM outgrowth,
Bmpr1a expression was detected more consistently until, finally,
all ESCs (14/14) showed strong expression. This suggests that
all ESCs have the potential to respond to Bmp4 signaling
(Figure 2C). Conversely, for Bmp4, all ICM cells (14/14) showedhigh expression, but this declined during the course of ICM
outgrowths so that ultimately only about 50% (7/14) of individual
ESCs retained Bmp4 expression (Ct = 25–40). This is compatible
with the fact that maintenance of ESCs can be achieved by the
addition of exogenous Bmp4 or serum, which contains Bmp4
(Ying et al., 2003).
During the course of ICM outgrowth toward ESCs, we found
clear upregulation of several genes, including Tcf15, Prdm5,
Zic3, Ifitm1,Nodal, andBex1, indicating that theymay potentially
be important during the transition to ESCs and/or for their subse-
quent maintenance (Figure 2D). Indeed, Nodal is a known regu-
lator of self-renewal but is not essential for the pluripotency of
ESCs (see below). By contrast, there was clear downregulation
of some genes during ICM outgrowth, such as Gata4, Gata6,
Pramel7, Tbx3, Bmi1, Bcl2l14, Nr5a2, and Amhr2, which poten-
tiallyhave ICMspecificdevelopment-relatedfunctions (Figure2E).
For example, ICMhas thepotential to develop intoprimitive endo-
derm cells, for which Gata4 and Gata6 are crucial regulators
(Fujikura et al., 2002; Koutsourakis et al., 1999; Morrisey et al.,
1998). Thus, repression of these genes may allow ICM cells to
exit from their inherent developmental program as they acquire
the ability for self-renewal while retaining pluripotency as ESCs.
Molecular Changes during the Transition
from ICM to ESCs
To understand the dynamic nature of gene expression in indi-
vidual cells at the whole-genome scale, we randomly selected
12 individual ESCs and generated their digital transcriptome
profile (Figure 3A, Figure S2, and Tables S2 and S3) (Tang
et al., 2009). Indeed, all of the 12 ESCs analyzed had high
expression of Oct4, Sox2, Nanog, Rex1 (also known as Zfp42),
Dppa5, and Utf1, which indicates that all of them are in an undif-
ferentiated state and are pluripotent. To confirm the reliability of
our single-cell RNA-Seq approach, we compared our data with
that obtained from bulk analysis of ESCs (Cloonan et al., 2008).
We found that on average, an individual ESC expresses 10,815
genes (RPM > 0.1), which means that we captured expression
of at least 94.6% of the genes in a single cell of those detected
by deep sequencing in bulk assays of ESCs (Cloonan et al.,
2008). Overall, 65.8% (13,326 out of 20,259) of known genes
were expressed in 12 single ESCs, which shows that our
RNA-Seq data represent an accurate reflection of the entire
transcriptome in ESCs at single-cell resolution.
To understand the relationship between ESCs and the ICM/
Epiblast cells from which they were derived, we compared the
single-cell RNA-Seq transcriptomes of these cells (Figure S2)
to determine the extent to which ESCs resemble E3.5 ICM or
E4.5 Epiblast cells (Nichols et al., 2009). We found that the
molecular signature of all undifferentiated ESCs maintained
under our culture conditions are clearly different from both ICM
and epiblast cells based on the principal component analysis
of their transcriptomes. This means that at the molecular level,
ESCs are distinct from E3.5 ICM or E4.5 Epiblast (Figure 3A).
We detected a large set of genes, which show clear differential
expression between ICM/Epiblast and ESCs. (Table S2 and Fig-
ure S3. Note 2,475 genes with fold change, FC[ESC/ICM] > 4,
p < 0.01, and 2,362 genes with FC[ESC/ICM] < 0.25, p < 0.01;
2,110 geneswith FC[ESC/Epiblast] > 4, p < 0.01 and 1,170 genes
with FC[ESC/Epiblast] < 0.25, p < 0.01).Cell Stem Cell 6, 468–478, May 7, 2010 ª2010 Elsevier Inc. 469
Figure 1. Morphology of ICM Outgrowth
Bright field and fluorescence image ofmouse E3.5 blastocyst (day 0 ICMoutgrowth) (A andB), E4.5 blastocyst (C andD), day 3 ICMoutgrowth (E and F), day 5 ICM
outgrowth (G andH), and ESCs (I and J); real-timePCRmeasured gene expression in single cells of ICMoutgrowth:Oct4,Sox2, andNanog expression in 22 single
E3.5 ICM cells (K), in 10 single E4.5 epiblast cells (L), in 26 single day 3 ICM outgrowth cells (M), in 17 single day 5 ICM outgrowth cells (N), and in 23 single ESCs
(O). The y axis is normalized expression levels based on the mean expression values of all single cells for the given gene.
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million reads, 1 < RPM < 10), showed higher cell-to-cell varia-
tions than the ones expressed at high levels (RPM> 10, Figure 4),
which indicates that the former set of genes have a higher
propensity for a more dynamic regulation of expression among
individual cells of the same type. These genes include Hoxd13,
Hoxb3, Hoxb5, and Ddx3y that showed highly variable expres-
sion in ESCs, whereas Gm364, Tmem80, Hdx, Trpm3, Enox2,
Ilvbl, Has3, Pygm, and Fbxw13 showed a great variation in
expression within ICM cells. Some genes, such as Tnk1, Myof,
Adamts9, Tspan12, Rhox6, Epha7, Dhrs3, Fam189a1, and
Nudt18, showed highly variable expression in both ESCs and
ICM (Table S2). These variations are probably not because of
technical reasons because genes expressed at low levels
(RPM < 1) showed less cell-to-cell variation compared to genes
expressed at mid levels. For these genes with large coefficient of
variations (CV > 1) between cells of ESCs and ICM, Gene
Ontology (GO) analysis showed that the genes involved in
cellular growth, cellular assembly, amino acid metabolism, and
lipid metabolism were significantly enriched (p < 0.0001).
Next, we wanted to establish what general trends exist in gene
expression changes during the transition from ICM to ESCs. GO
analysis showed that for genes that changed dramatically in
their expression from ICM to ESCs (FC[ESC/ICM] > 4, or < 0.25,
p < 0.01), we found strong enrichment of genes for transcription-470 Cell Stem Cell 6, 468–478, May 7, 2010 ª2010 Elsevier Inc.related processes, such as DNA-dependent regulation of
transcription (enrichment > 1.5, p < 2.5 3 1014), transcription
factor activity (enrichment > 1.45, p < 2.63 1011), transcription
regulator activity (enrichment > 1.51, p < 4.2 3 109), positive
regulation of transcription from RNA polymerase II promoter
(enrichment > 1.51, p < 2.0 3 107), and transcription repressor
activity (enrichment > 1.4, p < 1.8 3 105, Table S4). For
example, 29 out of the 34 genes of the nucleic acid metabolism
pathway and 25 out of the 32 genes of lipid metabolism pathway
showed dramatic changes in their expression between ICM and
ESCs (Figures S5A and S5B). We also found clear enrichment of
cell-fate-related pathways, such as cellular development (24 out
31 genes), organismal development (27 out of 33 genes), and
cellular assembly and organization (32 out of 35 genes), indi-
cating a shift in the developmental potential from ICM to ESCs.
On the other hand, we found significant similarities in sig-
naling-related processes (including signal transduction, signal
transducer activity, receptor activity, G protein coupled receptor
activity, and G protein coupled receptor protein signaling
pathway), indicating that their expression is relatively compa-
rable in ICM and ESCs (Table S4). However, ESCs have the
ability to self-renew, whereas ICM does not. Thus, the 4,837
genes differentially expressed between ICM and ESCs might
provide insights into genes that regulate self-renewal ability
and unique metabolism in ESCs. To confirm the reliability of
Figure 2. Gene Expression Measured by
Real-Time PCR
Gene expression measured by real-time PCR in
single cells of fourteen ICM (E3.5), six day 3 ICM
outgrowth cells, nine day 5 ICM outgrowth cells,
and 14 ESCs (Table S1).
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Single-Cell RNA-Seq Profiling of ICM Outgrowthour observations on differentially expressed genes by our single-
cell RNA-Seq, we compared 108 genes that were detected by
both real-time PCR (Ct < 32) and RNA-Seq (>0.1 RPM) and found
that their correlation coefficient is 0.92, confirming the accuracy
of our single-cell RNA-Seq data (Figure S3).Cell Stem Cell 6, 468–Alternative Splicing during the ICM
Outgrowth at Whole-Genome Scale
Alternative splicing plays an important
role in defining tissue identity and speci-
ficity. It is estimated that nearly 95% of
the mammalian multiexon genes express
multiple transcript variants through alter-
native splicing (Chen and Manley, 2009).
We wished to know if alternative splicing
was a major feature during the outgrowth
process of ICM toward ESCs. We ad-
dressed the expression dynamics of all
the 6,331 transcript variants from the
2,567 RefSeq genes with multiple known
isoforms, which has not been addressed
previously. 1,852 transcript variants were
expressed (at least 5 counts) in either ICM
or ESCs. And from them, 417 transcript
variants were upregulated (fold change,
FC[ESC/ICM, splicing] > 2, p < 0.01),
and 586 transcript variants were clearly
downregulated (FC[ESC/ICM, splicing]
< 0.5, p < 0.01) (Figure 5; Table S2).
Thus, there was a dramatic change in
54.2% (1,003 out of 1,852) of the ex-
pressed transcript isoforms during ICM
outgrowth. Interestingly, we found that
epigenetic regulators, such as transcript
variants of heterochromatin binding pro-
tein Cbx5 (also known as Hp1a), Setdb1
(also known as Eset), Suv39h2, Ehmt2
(also known as G9a), Suv12, Kdm4a(also known as Jmjd3), Sirt2, Smarcb1, and Kat2a (also known
as Gcn5), showed between 2- and 132-fold change during ICM
outgrowth. More importantly, there were 128 transcript variants
expressed in ICM cells that were completely lost in ESCs.
Conversely, 169 variants that were not expressed in ICM wereFigure 3. Transcriptome Analysis of ICM
Outgrowth Cells
(A) The principal component analysis of ICM
outgrowth cells. The nine E3.5 ICM, three E4.5
Epiblast, two day 3 Oct4+Sox2+Nanog+ outgrowth
cells, three day 5 Oct4+Sox2+Nanog+ out-
growth cells, two day 5 Oct4Sox2Nanog
outgrowth cells, and twelve ESCs are indepen-
dently clustered (Table S2).
(B) Expression dynamics of marker genes of early
primordial germ cells (PGCs). Averaged expres-
sion of different individual cells was shown. The
error bar represents the coefficient of variation
(CV) between individual cells.
478, May 7, 2010 ª2010 Elsevier Inc. 471
Figure 4. Plots of the Distribution of Coeffi-
cient of Variation between Individual Cells
158 (A) and 117 (B) genes are detected by TaqMan
real-time PCR (Ct < 32 in at least half of the cells)
in ESC and ICM cells, respectively, and used to
compare cell-to-cell measurement variance.
Density of coefficients of variation (CVs) for Ct
measurements (blue) and RPM measurements
representing RNA-Seq transcripts counts per
million reads (red) across both ESC (A) and ICM
(B) show a small difference between the two plat-
forms. A similar representation is generated using
the entire set of transcripts (24,435) separated
into three categories: highly expressed genes
(RPM > 10, aqua blue), mid-expressed genes
(1 < PRM < 10, blue), and low-expressed
genes (RPM < 1, green). CV density of each group
of transcripts is represented for ESC (C) and ICM
(D). The red curves are the sum of high-, mid-
and low-expressed genes density of CVs. The
mid-expressed genes tend to have higher cell-
to-cell variations (Table S2). For each transcript,
RPMs were used to calculate mean and standard
deviation across cells of the same type. CV was
defined as the ratio between the standard devia-
tion and the mean value.
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Single-Cell RNA-Seq Profiling of ICM Outgrowthclearly expressed in ESCs (Figure S4). Correspondingly, the
expression of tissue-specific alternative splicing factors strongly
changed (5- to 60-fold) during ICMoutgrowth, suchasnPTB (also
known as Ptbp2), Rbm35b (also known as Esrp2), Tia1, Slm2
(also known as Khdrbs3), Celf4 (also known as Brunol4), and
Celf5 (also known as Brunol5). Thus, there were global changes
in the regulation of alternative splicing during ICM outgrowth.
GOanalysis of transcription variants showed that thegeneral cell
metabolism-relatedprocesses, suchasmRNAprocessing (enrich-
ment > 1.41, p < 0.02), RNA splicing (enrichment > 1.56, p < 0.015),
protein modification processes (enrichment > 2.41, p < 0.0037),
cytoskeleton (enrichment > 1.27, p < 0.007), microtubule (enrich-
ment>1.57,p<0.008), carbohydratemetabolicprocesses (enrich-
ment > 1.65, p < 0.03), modification-dependent protein catabolic
processes (enrichment > 1.3, p < 0.03), are clearly enriched for
these transcript variants (Table S4). This suggests that one of the
main sources of global regulation of alternative splicing from ICM
to ESCs probably reflects the accommodation of ICM cells from
in vivo embryonic environment to ESC in vitro culture condition,
which might be important for the regulation of basal cell metabo-
lism. Furthermore, cell-cycle-related processes (including cell
division and mitosis) are also enriched in these significantly up- or
downregulated transcript variants, indicating the potential differ-
ences in cell-cycle regulation between ICM and ESCs.
Expression Dynamics of Epigenetic Regulators during
the ICM Outgrowth
Since the process of ICM outgrowths and formation of ESCs
involves arrest of a normal developmental program and initiation472 Cell Stem Cell 6, 468–478, May 7, 2010 ª2010 Elsevier Inc.of self-renewal while retaining pluripo-
tency, it is likely that epigenetic regula-
tors may have an important role during
this process. For this reason, weanalyzed the expression of 114 known key epigenetic regulators
(Table S4). We found that 37 of them showed strong upregula-
tion and 16 of them were clearly downregulated. Thus 46.5%
(53 out of 114) of known epigenetic regulators showed changes
in expression, which may be necessary to underpin the pheno-
typic changes in these cells. More importantly, the majority of
the epigenetic regulators that show increased expression are
linked to a repressive epigenetic status. Thus, for DNA methyla-
tion, Dnmt3a, Dnmt3b, Dnmt3l, Mecp2, and Mbd2 increased
between 2- and 12-fold from ICM to ESCs. Similarly, histone
deacetylases Hdac5, Hdac6, Hdac7, Hdac11, H3K9 methyl-
transferase Ehmt1 (also known as Glp), H4K20 methyltransfer-
ase Suv420h2, and heterochromatin binding protein Cbx1
(also known as Hp1b) increased from 2- to 40-fold. Conversely,
a large proportion of the epigenetic modifiers known to confer an
active epigenetic status were downregulated. These include
histone acetyltransferases Ncoa3 (also known as ACTR),
Crebbp (also known as CBP/P300), Clock, H3K9 demethylases
Kdm4a (also known as Jhdm3a), Kdm4d (also known as
Jmjd2d), H3K27 demethylase Kdm6b (also known as Jmjd3),
and H3K4 methyltransferaseMll3 (also known as Kmt2c), which
showed between 2- and 10-fold downregulation from ICM
outgrowth to ESCs.
These results indicate that ESCs probably have a globally
more repressive epigenetic status compared with the ICM. Since
ICM cells in vivo undergo rapid and transient phenotypic and
developmental changes in the course of early postimplantation
development, these cells may require a greater epigenetic flexi-
bility. By contrast, themore repressive epigenetic status of ESCs
Figure 5. Splice-Specific Differential Expression
The coverage plots of two junctions in (A) ESC, (B) E3.5 ICM, and (C) E4.5 epiblast of Dppa4 gene. The junction counts of Dppa4 transcript variant no. 1
(NM_001018002) are 12.47-fold more in ICM (88 reads, RPM = 150.16) than that in ESC (13 reads, RPM = 12.03), while the junction counts of Dppa4 transcript
variant no. 2 (NM_028610) are 2.2-fold less in the ICM (35 reads, RPM = 59.72) than that in ESC (142 reads, RPM = 131.43, Table S2). RPM, read per million
aligned reads.
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their undifferentiated pluripotent state while retaining the
capacity for infinite self-renewal.
Correlation between Gene Expression, Pluripotency,
Cell Differentiation, and Cell Fate
Next, we examined in greater detail changes in gene expression
to further assess the differences between ICM and ESCs
(Figure S2). Whereas ESCs and ICM are both pluripotent, the
phenotype of ESCs is relatively constant as they undergo self-
renewal, while ICM cells cannot do so in vivo because they are
poised to undergo further changes according to their develop-
mental program (Smith, 2006; Niwa, 2007). From this analysis,
we found four clusters of interesting genes related to pluripo-
tency and self-renewal (Figure S6).The first cluster of genes is upregulated during ICM outgrowth,
such as Nodal, Eras, Lin28, Smad1, Zic3, Id1, Id2, Tcf3, Kit (also
known as c-Kit), Kitl (also known as Scf), Prdm5, Prdm16, Klf12,
Zfp41, Sox3, Ifitm3 (also known as Fragilis), Pim2, Cdh3 (also
known as P-cadherin), and Nr0b1 (also known as Dax1); these
genes correlate positively with the capacity for self-renewal
exhibited by ESCs. Indeed, this trend is confirmed by the anal-
ysis of cells in day 5 ICMoutgrowths that have ceased to express
pluripotency genes, where this first cluster of genes is downre-
gulated (Figure S6A). While some of the genes in this cluster
were shown to be important for pluripotency, we suggest that
at least some of them are probably also important for self-
renewal. In fact, Eras and Nodal that were recovered in this
cluster are two known regulators that are crucial for the self-
renewal of ESCs but are not essential for pluripotency (TakahashiCell Stem Cell 6, 468–478, May 7, 2010 ª2010 Elsevier Inc. 473
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Single-Cell RNA-Seq Profiling of ICM Outgrowthet al., 2003; Ogawa et al., 2007). For example, interference with
the Nodal signaling has a strong effect on the self-renewal and
proliferation of ESCs, but there is little effect on their pluripotency
(Ogawa et al., 2007). The loss of Eras has a similar effect on the
properties of ESCs (Takahashi et al., 2003).
The second cluster of genes is downregulated during ICM
outgrowth, such as Gata3, Gata4, Gata6, Cdx1, Cdx2, Pramel5,
Pramel6, Pramel7, Sox17, Bmp15, Dppa1, Tbx3, Tbx20, Gdf9,
Hoxd8,Gsc, and Klf17. Some of these are developmental genes,
including Cdx2 and Gata6, which are required for development
of the extraembryonic cells, trophectoderm and primary endo-
derm, respectively (Ralston and Rossant, 2008; Johnson et al.,
2006; Koutsourakis et al., 1999), but they are apparently not
essential for the self-renewal of ESCs (Figure S6B).
The third cluster of genes is highly expressed during ICM
outgrowth, except in those neighboring cells that cease to be
pluripotent as judged by the loss of expression of Oct4, Sox2
and Nanog, as well as Esrrb, Cdh1 (also known as E-cadherin),
Pecam1, Pim1, Pim3, Notch1, Notch4, Fzd9, Frz10, Dazl,
Prdm14, Bmp8b, and Dppa4, demonstrating a positive correla-
tion with the pluripotency of ICM and ESCs (Figure S6C). Indeed,
Esrrb, E-cadherin, Pim1, Pim3, and Prdm14 have been shown
to be important for pluripotency of ESCs (Ivanova et al., 2006;
Chou et al., 2008; Aksoy et al., 2007; Tsuneyoshi et al., 2008).
The fourth cluster of genes is confined to cells that have
ceased to be pluripotent as evident by the loss of expression
of the Oct4-DPE-GFP reporter. This cluster of genes include
Hoxd8, Bmp1, Bmp2, Tgfbr2, Tgfbr3, Jak2, Fgf3, Fgf10, Fgfr3,
Fgfr4,Sox7,Sox9,Sox17,Nanos1,Cdh5 (also known asVE-cad-
herin), and Nkx6.2, showing a negative correlation with the pluri-
potency of ESCs (Figure S6D). This cluster represents the
earliest set of differentiation genes that are activated when the
cells have just ceased to be pluripotent. For example, Fgf
signaling has been shown to promote differentiation of ESCs
(Kunath et al., 2007; Stavridis et al., 2007). Similarly, Sox7 and
Sox17 also drive ESC differentiation (Se´guin et al., 2008).
We also examined expression of primordial germ cell-specific
genes during the course of blastocyst outgrowths (Zwaka and
Thomson, 2005). We looked at the expression dynamics of early
PGC markers during this process (Figure 3B; Table S2). We
detected upregulation of Ifitm3 (also known as Fragilis),
Prdm14, Ddx4 (also known as Vasa) and Nanos3, but Dppa3
(also known as stella) was downregulated. We also found upre-
gulation of Prdm1 (also known as Blimp1), but later in ESCs,
and the levels were highly variable in individual cells (Table S2).
However, all these genes were repressed in the Oct4 negative
outgrowth cells that had lost pluripotency. Further studies are
required to assess the significance of these observations, if
any, for the derivation and properties of ESCs.
Functional Downstream Genes of Pluripotency
Master Genes
The RNA-Seq analysis we have carried out provides an opportu-
nity to identify pluripotency genes and their downstream targets,
by comparing neighboring cells that are pluripotent to those that
show a loss of pluripotency under the same culture conditions.
These gene sets can also be compared with the expression of
the earliest genes that are downregulated when ESCs are
induced to differentiate in response to retinoic acid (RA) (Ivanova474 Cell Stem Cell 6, 468–478, May 7, 2010 ª2010 Elsevier Inc.et al., 2006). We found a good correlation between our data and
that reported previously with respect to 200 genes that were
downregulated in both instances (Figure S6E). It is likely that
our assay captured the earliest responding pluripotency genes,
because we compared pluripotent cells and the corresponding
earliest differentiated cells cultured under the same conditions.
Next, we asked if it is possible to determine the downstream
targets of key pluripotency genes by analyzing genes that were
downregulated in the day 5 outgrowth that had just ceased to
be pluripotent. We compared our data with the reported effects
of knockdown of Nanog, Sox2,Oct4, or Esrrb—genes described
previously (Ivanova et al., 2006). We found clear overrepresenta-
tion of downregulated genes detected following loss of Nanog
(p = 2.2 3 1016), Oct4 (p = 2.2 3 1016), Sox2 (p = 2.2 3
1016), or Esrrb (p = 1.63 107) (Figure S6F). Furthermore, there
was also strong overrepresentation of upregulated genes
following knockdown of Nanog (p = 2.03 108), Oct4 (p = 2.53
1010), or Sox2 (p = 2.2 3 1016) (Figure S6G). This shows that
our analysis serves as a good indicator of targets of pluripotency
genes. Moreover, detection of these probable target genes that
are regulated by corresponding pluripotency genes is cell-
autonomous as seen by RNA-Seq within an individual cell, which
excludes possible variable responses in individual cells analyzed
in bulk cultures.
To gain insight into the gene network underlying pluripotency,
we aligned our data to the known gene network for Oct4 associ-
ated with embryonic stem cell pluripotency (Loh et al., 2006,
2008; Sharov et al., 2008). We found that this network is enriched
in genes whose expression changed as judged by the compar-
ison of pluripotent and neighboring nonpluripotent cells present
within day 5 outgrowths. In fact, 22 out of the 45 Oct4 network
genes changed their expression significantly by more than
4-fold. Of these 22 genes, only two genes, namely Rb1 and
Foxa2, were not directly regulated by Oct4 (Figure 6; Table S4).
This suggests that through single-cell digital transcriptome
approach, we captured a large proportion of genes that are
directly regulated by Oct4 in the network (p = 4.02 3 106)
(Loh et al., 2006; Sharov et al., 2008). To our knowledge, this
is the first time that the Oct4 gene network is validated in an
individual cell, proving the cell-autonomous regulation of the
network, which is an essential prerequisite for direct interactions
within the gene network. Furthermore, we also aligned our data
to the known gene network for human embryonic stem cell
pluripotency and found a similar enrichment pattern. Forty-five
out of the 137 human ESC network genes significantly changed
their expression (p = 2.18 3 104, Figure S5C), suggesting
conservation of the core aspects of the gene network of pluripo-
tency between mouse and human, despite some known differ-
ences between them.
Segregation of MicroRNAs Repressing Early
Differentiation and Those Repressing Pluripotency
We next wanted to see if microRNAs (miRNAs) have a role in the
ICM outgrowths as they develop toward ESCs (Zamore and
Haley, 2005; Gangaraju and Lin, 2009). Expression analysis of
330 miRNAs showed similar expression of pluripotency related
miR-290 to -295 cluster in ICM and ESCs (Table S5; Figure 7A),
while a set of 51 out of 330 miRNAs showed differential expres-
sion (Figure 7B). We found that let-7a, let-7e, let-7f, and let-7g
Figure 6. Gene Network Analysis of Oct4 in Embryonic Stem Cell Pluripotency Pathway
The 22 genes (including Oct4) up/downregulated for more than 4-fold when the pluripotent cells lose pluripotency (FC[day 5 Oct4+/day 5 Oct4] > 4 or < 0.25,
p < 0.01) were shown in red. The gray colored genes have FC[day 5 Oct4+/day 5 Oct4] < 4 and FC[day 5 Oct4+/day 5 Oct4] > 0.25 (Table S4). The p value was
estimated using Ingenuity systems software (http://www.ingenuity.com). FC, fold change.
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which is reflected in the reduced levels of let-7 expression
required for the self-renewal and maintenance of undifferenti-
ated cancer stem cells (Yu et al., 2007). Correspondingly, we
found 5-fold upregulation of Lin28, which is the suppressor of
let-7 family miRNAs (Viswanathan et al., 2008). Recently, Card
et al. (2008) reported that miR-302 cluster in human ESC is
actively regulated by Oct4 and Sox2, while miR-302a targets
cell-cycle regulators and promotes an ESC-like cell cycle. Our
miRNA profiling indicated that two members of miR-302 cluster,
miR-302c and miR-367, increased 5- and 33-fold, respectively,
from ICM to ESCs, which may contribute to the capacity for
self-renewal of ESCs.
To explore the potential roles of miRNAs in regulating ESCs,
we used the target prediction algorithms of PicTar, Miranda, or
TargetScan (Krek et al., 2005; Lewis et al., 2005; Enright et al.,
2003). To reduce possible ‘‘prediction noise,’’ we considered
only those targets that are predicted by at least two algorithms.
For the miRNAs highly expressed in both ICM and ESCs, there
are two classes: the first class of miRNAs preferably target early
differentiation genes (FC[Day5 Oct4+/Oct4] < 0.25, r < 0.6,
Table S6 and S7) (miR-19b, -19a, -106a, -20b, -106b, -9, -103,
-107, -124a, -145; the target enrichment is 2.0-fold, p < 3.8 3
106). As a control, the targets of these ten miRNAs show no
enrichment (p > 0.02) for pluripotency-related genes (FC[Day5
Oct4+/Oct4] > 4, r > 0.6). The loss of this class of miRNAs
may contribute to the phenotype of loss of pluripotent Oct4-
positive epiblast cells when Dicer is knocked out in early
embryos (Bernstein et al., 2003). The second class of miRNAspreferably target the ESC-specific pluripotency genes
(FC[ESC/ICM] > 4) (miR-669b, -298, -692, -204, -28, -149,
-34a, -182, [-129-5p, -133a, -320; the target enrichment is
1.6-fold, p < 1.33 108). As a control, the targets of these eleven
miRNAs show no enrichment (p > 0.03) in ICM-specific genes
(FC[ESC/ICM] < 0.25). The loss of this class of miRNAs may
contribute to the phenotype of resistance to differentiation
when Dicer or DGCR8, two key components of the miRNA
processing pathway, are knocked out in established ESCs
(Kanellopoulou et al., 2005; Wang et al., 2007). Taken together,
miRNAs may contribute to ESC’s ability to maintain the balance
between pluripotency and the potential for rapid differentiation,
through one set of miRNAs targeting genes that drive differenti-
ation, while a separate set of miRNAs target ESC-specific pluri-
potency genes.
Conclusion
Our study provides insight into the dynamic molecular changes
that accompany cell-fate changes. During the conversion of
ICM cells to ESCs, there is an evident arrest of a normal develop-
mental program, which is subverted in vitro in favor of a potential
for unrestricted self-renewal while retaining the ability to undergo
differentiation into all the diverse cell types. We demonstrate
how both the retention of expression of key genes allows inher-
itance of a fundamental property of the ICM, namely pluripo-
tency, while other changes in the transcriptome permit exit
from a normal developmental program and confer a key property
of self-renewal. Changes in epigenetic regulators apparently
allow for the stability of the newly acquired epigenotype, whichCell Stem Cell 6, 468–478, May 7, 2010 ª2010 Elsevier Inc. 475
Figure 7. MicroRNA Expression in ICM and
ESCs
(A) miR-290 295 cluster microRNA expression
in ICM and ESCs.
(B) microRNAs showing significant differential
expression between ICM and ESCs (p value <
0.01). The relative expression levels were shown
(Table S5). The error bar represents the standard
deviation calculated from three biological repli-
cates.
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ICM to ESC is also coupled with a role for distinct sets of miRNAs
that allow for both self-renewal while the cells retain the ability to
respond rapidly to cues for differentiation. Our investigation may
serve as a paradigm for other studies, including regulation and
differentiation of small numbers of stem cells in adults. Our
approach is applicable to studies on small groups of differenti-
ating cells and for gaining insight into how developmental
programs might be undermined, leading to the formation of
diseased tissues, including cancers.EXPERIMENTAL PROCEDURES
Isolation of Embryos and Single Cells
All embryos were recovered from 129 females mated with Oct4-DPE-GFP
transgenic male mice. The transgenic GFP expression of the reporter is under
the control of Oct4 promoter and distal enhancer, but the proximal enhancer
region is deleted. This GFP transgene reporter shows expression in the E3.5
ICM and E4.5 Epiblast of blastocysts and PGC in vivo and in ESC (Yeom
et al., 1996). E3.5 and E4.5 blastocysts were flushed from the uterus of 129
pregnant females. For ESC outgrowth, E3.5 blastocysts were cultured in
KSOM medium for the first day and then transferred to GMEM medium
(GIBCO, cat. no. 21710-025) with 15% Fetal Calf Serum (FCS) (GIBCO, cat.
no. 16000-044) and 1000 U/ml Lif on mitomycin C-treated MEF feeder cells
for all later periods. The time when the E3.5 blastocysts were placed into
culture was designated as day 0.
For the isolation of single cells of E3.5 ICM or E4.5 epiblast, the blastocysts
were first placed in a mouse trophoblast antibody for 30 min. Then they were
treated by complement for 30 min. After this, the lysed trophectoderm cells
were removed and the isolated ICM or epiblast was placed in EGTA-PBS for
10 min. After that, they were furthered treated by Trypsin at 37C for 5 min.
Then they were transferred into GMEM medium with 15% FCS and dissoci-
ated into single-cell suspension. The resulting single cells were washed in
BSA-PBS twice and prepared to be picked as single cells.
For the isolation of blastocyst/ICM outgrowth, it was treated by trypsin for
5min to dissociate the core part of outgrowth from surrounding trophectoderm476 Cell Stem Cell 6, 468–478, May 7, 2010 ª2010 Elsevier Inc.progenies. The inner core of cells in the outgrowth
was treated with EGTA-PBS for 10 min at room
temperature and trypsin for 5 min at 37C. The
core of cells was dissociated by pipetting into
a single-cell suspension in GMEM medium with
15% FCS. Next, the GFP-positive and -negative
cells were separated manually under a fluores-
cence microscope. The single cells were washed
in BSA-PBS twice before theywere picked individ-
ually for subsequent analysis.
Preparation of Single-Cell cDNAs
The single-cell RNA-seq method has been
described in detail previously (Tang et al., 2009,
2010). In brief, an individual cell was manually
picked and transferred into lysate buffer bya mouth pipette, followed by reverse transcription directly on the whole-cell
lysate. Following this procedure, terminal deoxynucleotidyl transferase was
used to add a poly(A) tail to the 30 end of first-strand cDNAs, which was fol-
lowed by 20 + 9 cycles of PCR to amplify the single-cell cDNAs.
RNA-Seq Library Preparation, Sequencing, and Alignment
After generation of the target cDNA from a single cell, 100 ng cDNA (0.5–3 kb)
was sheared into 80–130 bp fragments. P1 and P2 adaptors were ligated to
each end, and the fragments were subjected to 8–10 cycles of PCR amplifica-
tion. Emulsion PCR reactions were performed by combining 1.6 billion 1 mm
diameter beads that had P1 primers covalently attached to their surfaces
with 500 pg of single-cell libraries. Applied Biosystems SOLiD sequencer
generated 50-base sequences, and AB’s whole transcriptome software tools
were used to analyze the sequencing reads (http://solidsoftwaretools.com/gf/
project/transcriptome/). The reads obtained from each cell were matched to
the Mouse genome (mm 9, NCBI Build 37) and reads that aligned uniquely
were used in the downstream analysis. These reads were used to create
base coverage files (in a wiggle format), which can be viewed directly in the
UCSC genome browser, or to detect known or novel exon-exon junctions.
Unambiguously mapped reads were first used to generate exon counts and
then transcript or gene counts. Feature counts were normalized using the
RPM (read per million aligned reads) method, and no adjustment to gene/
transcript size was made because our protocol has a limited coverage of
0.5–3 kb from the 30 end of the transcripts. An alternative analysis was used
for alignments that were not aligned to their full length, where reads were
aligned to a reference containing exon-exon junctions, using 42 bases on
each side for junctions, allowing up to four mismatches for the full length
of the read (50 bases) (Tang et al., 2009). The quality of the single-cell
RNA-Seq data was analyzed (Figure S7). These analyses showed that our
single-cell RNA-Seq data are highly reproducible, reliable, and accurate for
ICM outgrowth and ESCs.
Real-Time PCR
For TaqMan real-time PCR, 1.0 ml of diluted cDNAs was used for each 10 ml
real-time PCR (13 PCR Universal Master Mix, 250 nM TaqMan probe, 900
nM of each primer, that are commercially available as ready to use Assays,
custom-plated in 384-plates or TaqMan low Density Array cards by Applied
Biosystems). All reactions were duplicated. The PCR was done as following
Cell Stem Cell
Single-Cell RNA-Seq Profiling of ICM Outgrowthusing an AB7900 with 384-well plates: first, 95C for 10 min to activate the Taq
polymerase, then 40 cycles of 95C for 15 sec and 60C for 1 min.
MicroRNA Profiling of ICM and ESCs
The detailed protocol is described previously (Tang et al., 2006). In brief,
10 cells were picked into a PCR tube by glass capillary and were lysed by
heat treatment at 95C for 5 min. Then the microRNAs were reverse tran-
scribed into cDNAs by pool of 330 of stem-looped primers. After this, these
microRNA cDNAs were amplified by 18 cycles of PCR by 330 forward primers
and a universal reverse primer. Finally the cDNAswere split and each individual
microRNA was measured by TaqMan probe-directed real-time PCR. Three
biological replicates were done for each type of cell.
ACCESSION NUMBERS
All of the raw data of single-cell RNA-Seq for ICM outgrowth have been depos-
ited in the high-throughput sequencing database of GEO (accession number
GSE20187).
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